IHG Genotech Symposium September 9, 2024 Agenda

  Time Who Title Talk Title
Introductions 9:00-9:10 Kathy Giacomini Dean, School of Pharmacy, UCSF  
  9:10-9:15 Nadav Ahituv Director, Institute for Human Genetics, UCSF  
Gene Therapy 9:15-9:35 Christof Fellmann Head of CRISPR-X, Executive Director, CRISPR Therapeutics Translating gene editing to the clinic
  9:35-9:55 David Schaffer Professor, Director of QB3, Director of Bakar Labs, UC Berkeley Directed Evolution of Novel Adeno-Associated Viral Vectors for Clinical Gene Therapy
  9:55-10:25 Francine Gregoire Chief Scientific Officer, Addition Therapeutics PRINTing the Future: How Retrotransposons Will Transform Genetic Medicine
  10:25-10:45 Kyle Cromer Assistant Professor, Surgery, UCSF Using human genetics to increase production of clinically relevant cell types
  10:45-11:15 Panel Discussion    
Break 11:15-11:45      
Keynote Speaker 11:45-12:30 Emil Kakkis Founder, President and Chief Executive Officer, Ultragenyx The development of treatments for rare diseases: the impact of genetic technologies to open the path to first-ever treatments
Lunch & Career Panel 12:30-1:45 Christina Fan, Francine Gregorie, Emil Kakkis, and David Kelley  

The career panel will be a round table discussion. Nick Page, PhD student, will lead the discussion with a few questions to get the ball rolling and from there we can take questions from other PhD students and postdocs in the audience. Come learn more about exciting and impactful career paths in the biotech industry. To join simply take your lunch to room GH-N114 (on the first floor of the Genentech building).Tables and Moveable Chairs
AI 1:45-2:05 Andrew Carroll Product Lead Genomics in Google Research Deep Learning for Clinical Genetics and Cohort Genomics
  2:05-2:25 David Kelley Principal Investigator, Calico Life Sciences Predicting RNA-seq coverage from DNA sequence as a unifying model of gene regulation
  2:25-2:45 Danny Wells Founder - Santa Ana Bio, Immunai Lessons from the front lines of building platform biotherapeutics companies
  2:45-3:05 Tony Capra

Professor, Epidemiology & Biostatistics and Bakar Computational Health Sciences Institute, UCSF

 AI as a time machine: predicting ancient and future phenotypes with sequence-based machine learning
  3:05-3:25 Panel Discussion    
Break 3:25-3:55      

Genomic Technologies

 3:55-4:15 Christina Fan Co-Founder and Chief Technology Officer, Curio Bioscience Bringing spatial context to single-cell multiomic studies
  4:15-4:35 Andrew Farmer Chief Scientific Officer and Head of Research & Development, Takara Bio USA Driving biomarker discovery with high-throughput single-cell genome and transcriptome profiling
  4:35-4:55 Wenjun Ouyang Senior VP, Inflammation and Fibrosis, Data Science, Discovery Science & Technology, Gilead Exploring Treg dynamics and identifying CCR8 as a therapeutic target by scRNAseq in human cancers and preclinical models
  4:55-5:15 Yin Shen Professor, Neurology, UCSF Characterizing Human Genome Function at Base Pair Resolution
  5:15-5:45 Panel Discussion    
Reception in Rock Hall room RH-502 6:00-7:00